Hancock Whitney’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-25,561
Closed -$386K 831
2018
Q4
$386K Sell
25,561
-6,461
-20% -$97.6K 0.01% 659
2018
Q3
$592K Buy
+32,022
New +$592K 0.02% 613